相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Transdermal Vaccination with the Matrix-2 Protein Virus-like Particle (M2e VLP) Induces Immunity in Mice against Influenza A Virus
Kimberly Braz Gomes et al.
VACCINES (2021)
Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection
Amy S. Espeseth et al.
NPJ VACCINES (2020)
The journey to a respiratory syncytial virus vaccine
Asuncion Mejias et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2020)
Formulation of the prefusion RSV F protein with a Th1/Th2-balanced adjuvant provides complete protection without Th2-skewed immunity in RSV-experienced young mice
Jessica L. Kosanovich et al.
VACCINE (2020)
MPL and CpG combination adjuvants promote homologous and heterosubtypic cross protection of inactivated split influenza virus vaccine
Eun-Ju Ko et al.
ANTIVIRAL RESEARCH (2018)
Vaccination by microneedle patch with inactivated respiratory syncytial virus and monophosphoryl lipid A enhances the protective efficacy and diminishes inflammatory disease after challenge
Soojin Park et al.
PLOS ONE (2018)
The importance of RSV F protein conformation in VLPs in stimulation of neutralizing antibody titers in mice previously infected with RSV
Lori M. Cullen et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Muscle Histology Characterization Using H&E Staining and Muscle Fiber Type Classification Using Immunofluorescence Staining
Chao Wang et al.
BIO-PROTOCOL (2017)
Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells
Ki-Hye Kim et al.
JOURNAL OF VIROLOGY (2015)
Microneedle delivery of an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective influenza immunity
Bao-Zhong Wang et al.
JOURNAL OF CONTROLLED RELEASE (2014)
A recombinant anchorless respiratory syncytial virus (RSV) fusion (F) protein/monophosphoryl lipid A (MPL) vaccine protects against RSV-induced replication and lung pathology
Jorge C. G. Blanco et al.
VACCINE (2014)
Respiratory Syncytial Virus-A Comprehensive Review
Andrea T. Borchers et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2013)
Respiratory Syncytial Virus G Protein CX3C Motif Impairs Human Airway Epithelial and Immune Cell Responses
Tatiana Chirkova et al.
JOURNAL OF VIROLOGY (2013)
A Respiratory Syncytial Virus (RSV) Anti-G Protein F(ab′)2 Monoclonal Antibody Suppresses Mucous Production and Breathing Effort in RSV rA2-line19F-Infected BALB/c Mice
Seyhan Boyoglu-Barnum et al.
JOURNAL OF VIROLOGY (2013)
Applications of nanotechnology for immunology
Douglas M. Smith et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Microneedles for drug and vaccine delivery
Yeu-Chun Kim et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Adjuvants for human vaccines
Carl R. Alving et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Viruslike Particle Vaccine Induces Protection Against Respiratory Syncytial Virus Infection in Mice
Fu-Shi Quan et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Transcutaneous vaccines: Novel advances in technology and delivery for overcoming the barriers
Ni Li et al.
VACCINE (2011)
Memory CD4 T Cells Direct Protective Responses to Influenza Virus in the Lungs through Helper-Independent Mechanisms
John R. Teijaro et al.
JOURNAL OF VIROLOGY (2010)
Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus
Matthew R. Olson et al.
EXPERT REVIEW OF VACCINES (2008)
Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: An experimental murine model
Susana Chavez-Bueno et al.
VIROLOGY JOURNAL (2005)
分享论文
